T. Fadra

发表

Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitors.

K. Qian, J. Madwed, C. Pargellis, 2009, Bioorganic & medicinal chemistry letters.

Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase.

M. Hao, K. Qian, N. Moss, 2006, Bioorganic & medicinal chemistry letters.

Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase.

M. Hao, K. Qian, N. Moss, 2006, Bioorganic & medicinal chemistry letters.

Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects.

M. Emmanuel, Alison J Kukulka, G. Nabozny, 2014, Journal of medicinal chemistry.

Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.

T. Gilmore, J. Regan, C. Torcellini, 2011, Bioorganic & medicinal chemistry letters.

Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics.

T. Gilmore, C. Torcellini, Alison J Kukulka, 2010, Journal of medicinal chemistry.

Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand.

G. Nabozny, Ljiljana Žuvela-Jelaska, D. Kuzmich, 2005, Bioorganic & medicinal chemistry letters.

New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site.

K. Qian, J. Madwed, C. Pargellis, 2007, Bioorganic & medicinal chemistry letters.

Discovery and optimization of p38 inhibitors via computer-assisted drug design.

Angela Berry, Jinhua J. Song, Ming-Hong Hao, 2007, Journal of medicinal chemistry.

Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.

M. Hao, K. Qian, C. Pargellis, 2008, Bioorganic & medicinal chemistry letters.